News
CRUK RadNet Cambridge Seminar
30 Nov 2023
All are welcome to attend the next CRUK RadNet Cambridge seminar on Tuesday 30 November, 16:00-17:00 at the CRUK Cambridge Institute.
Professor Charlotte Coles receives top honour from Royal College of Radiologists
18 Sep 2023
Congratulations to Professor Charlotte Coles, CRUK RadNet Cambridge lead on being awarded the Gold Medal by the Royal College of Radiologists.
Radiotherapy boost cuts treatment time for breast cancer patients by at least a week
3 Jul 2023
Treatment times for radiotherapy could be reduced for some early breast cancer patients, according to a trial led by Professor Charlotte Coles and funded by Cancer Research UK.
AI cuts radiotherapy waiting times for NHS cancer patients
27 Jun 2023
Artificial intelligence developed by and for the NHS at Addenbrooke’s Hospital in Cambridge is reducing the amount of time cancer patients wait for radiotherapy treatment.
Most women diagnosed with early breast cancer today will beat the disease
13 Jun 2023
Waterbeach woman involved in the study welcomes results.
Centre members elected to Academy of Medical Sciences 2023
18 May 2023
Congratulations to Charlotte Coles, Eric Miska and Serena Nik-Zainal who have been elected to the Academy of Medical Sciences Fellowship.
First UK proton beam therapy trial for breast cancer launches
4 Jan 2023
A pioneering trial will determine potential benefits of proton beam therapy compared with standard radiotherapy for people at greater risk of developing long-term heart problems following radiotherapy.
Cambridge and Kolkata breast cancer researchers exchange ideas
2 Nov 2022
A meeting between Tata Medical Center Kolkata, RadNet Cambridge and our Precision Breast Cancer Institute highlights areas for collaboration.
Celebrating the role of patients in improving radiotherapy services
22 Sep 2022
A new display in Addenbrooke’s Hospital highlights how patients have helped shape radiotherapy treatment.
The Lancet announces Breast Cancer Commission
19 Feb 2022
Professor Charlotte Coles is to lead an international multidisciplinary team aiming to influence global policy and improve the lives of people at risk of, and living with, breast cancer.